Aberrant deposition of β‐amyloid (Aβ) and hyperphosphorylated tau, along with neuroinflammation, are key drivers of Alzheimer's disease (AD) pathology. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.